Loading
A phase 3 trial of Carmustine, Lomustine, Porfimer sodium and Procarbazine in Brain and spinal cord tumours, run by Colorado Health Foundation, with a status the registry has not verified recently.
Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas is a phase 3 interventional study registered as NCT00003788 by Colorado Health Foundation, with 270 participants planned, started 1998-04. Interventions recorded: carmustine, lomustine, porfimer sodium, procarbazine hydrochloride, neoadjuvant therapy, surgical procedure, radiation therapy. Conditions recorded: Brain and Central Nervous System Tumors.
Linked to the drug Porfimer sodium because the registry names it among its interventions and Brain and spinal cord tumours among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Lomustine (CCNU), Glioma & glioblastoma and the tag pipeline.
Shares Porfimer sodium and the tag pipeline.
Shares Porfimer sodium and the tag pipeline.
Shares Carmustine, Glioma & glioblastoma and the tag pipeline.
Shares Brain and spinal cord tumours (all types), Glioma & glioblastoma and the tag pipeline.
Shares Brain and spinal cord tumours (all types), Glioma & glioblastoma and the tag pipeline.
Shares Brain and spinal cord tumours (all types), Glioma & glioblastoma and the tag pipeline.
Shares Brain and spinal cord tumours (all types), Glioma & glioblastoma and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/